Kristin Patrick - 24 Jun 2025 Form 4 Insider Report for Niagen Bioscience, Inc. (NAGE)

Role
Director
Signature
/s/ Jeong James Lee, Attorney-in-Fact
Issuer symbol
NAGE
Transactions as of
24 Jun 2025
Net transactions value
$0
Form type
4
Filing time
26 Jun 2025, 17:29:03 UTC
Previous filing
26 Aug 2024
Next filing
03 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Patrick Kristin Director 10900 WILSHIRE BLVD. SUITE 600, LOS ANGELES /s/ Jeong James Lee, Attorney-in-Fact 26 Jun 2025 0001769529

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NAGE Stock Option (right to buy) Award $0 +20,000 $0.000000 20,000 24 Jun 2025 Common Stock 20,000 $14.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option vests 100% on June 24, 2026.